BioInformatics LLC New Market Report – The Market for Stem Cell Research Products: Current and Future Opportunities

BioInformatics LLC announces the November 30, 2012 release of their newest market report: The Market for Stem Cell Research Products: Current and Future Opportunities (12-005)

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Find out what you need to know about the stem cell products market.

Stem cell product suppliers can use the report to secure a leading position in this expanding market.

Arlington, VA (PRWEB) November 27, 2012

As stem cell research begins to yield actionable results, stem cell products suppliers are seeking ways to maximize opportunities in developing areas of stem cell research, alternative testing methods using stem cells in drug discovery and the emergence of innovative stem cell-based therapies. The Market for Stem Cell Research Products: Current and Future Opportunities was designed to help suppliers assess the market for stem cell products and lines: market size and share, new/future applications, scientists’ product preferences and the competitive landscape.

Additionally, The Market for Stem Cell Research Products: Current and Future Opportunities will contain trending data from BioInformatics LLC’s 2009 exploration of the stem cell products market.

The report is scheduled to release on November 30, 2012. Until December 14, 2012, the purchase of The Market for Stem Cell Research Products: Current and Future Opportunities will include the data set (normally a $1,200 value) at no extra charge.

The following are the suppliers who were presented in the survey as suppliers of stem cell lines and products:

Applied Stem Cell
ATCC
BD Biosciences
California Stem Cell
Cell Genix
GE Healthcare
PAA Laboratories
Life Technologies
Lonza
Merck/EMD Millipore
Miltenyi Biotec
PeproTech
R&D Systems
Sigma-Aldrich
Stem Cell Sciences
StemCell Technologies
Stemgent
System Bioscience
Thermo Scientific
Zen Bio

“Pharmaceutical and biotech companies are exploring stem cell opportunities with keen interest,” says Nicole Camara, Ph.D., the lead science analyst on the report team. “Stem cell research and therapies are on the rise, and despite heavy regulations, hold promise as a viable source of future revenue streams. Stem cell product suppliers can use the report to secure a leading position in this expanding market.”

To learn more about The Market for Stem Cell Research Products: Current and Future Opportunities, a complimentary Executive Summary (PDF) is available at gene2drug.com.

ABOUT BIOINFORMATICS LLC
BioInformatics LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 70,000 life scientists, we have supported more than 500 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.


Contact

Follow us on: Contact's Twitter Contact's LinkedIn